Dechra has announced the appointment of Anne-Francoise Nesmes, who will join the group and the board on April 22, 2013 from GlaxoSmithKline, where she has worked since 1997 in a number of finance roles.
Dechra has announced the appointment of Anne-Francoise Nesmes as chief financial officer. She will join the group and the board on April 22, 2013.
Anne-Francoise, a member of the Chartered Institute of Management Accountants, joins from GlaxoSmithKline (GSK) where she has worked since 1997 in a number of finance roles, including her current position as senior vice-president, finance, of vaccines based in Belgium.
With GSK, Anne-Francoise has developed her experience in a variety of roles including internal audit, corporate planning, commercial finance and, between 2003 and 2006, was vice-president and finance controller for Europe.
Prior to joining GSK Anne-Francoise had finance roles with John Crane, Tetra Pak, ADP and Caterpillar UK.
Anne-Francoise is a French national, holds an MBA from Henley Management College and a master in management sciences from Grenoble Business School.
Dechra chairman Mike Redmond said: “We are delighted that Anne-Francoise is joining Dechra. She is a high calibre finance professional who also has valuable international, pharmaceutical, manufacturing and commercial experience. She will be a welcome addition to the executive team.
“I, and the rest of the board, look forward to working with Anne-Francoise to continue to progress our strategy of delivering a high growth, cash generative, specialist veterinary products business.”